Evaluation of the performance of immunological parameters as indicators for clinical progression of chronic HTLV-1 infection;Avaliação do desempenho de parâmetros imunológicos como indicadores de progressão clínica da infecção crônica pelo HTLV-1

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 40, Issue 1, 2007, Pages 29-36

  Coelho dos Reis, Jordana Grazziela Alves ^a,b   Rocha, Roberta Dias Rodrigues ^a   Brito Melo, Gustavo Eustáquio Alvim ^c   Ribas, João Gabriel ^d   Carneiro Proietti, Anna Bárbara De Freitas ^e   Catalan Soares, Bernadete ^e   Barbosa Stancioli, Edel Figueiredo ^b   Martins Filho, Olindo Assis ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSIDADE FEDERAL DOS VALES DO JEQUITINHONHA E MUCURI   (Brazil)

^d Hospital Sarah Kubitschek   (Brazil)

^e Serviço de Pesquisa Fundação Centro de Hematologia E Hemoterapia de Minas Gerais HEMOMINAS   (Brazil)

Author keywords

HTLV 1; Immunophenotyping; Morbidity indicators; Performance indices

Indexed keywords

HLA DR ANTIGEN;

ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOLOGICAL PARAMETERS; IMMUNOPHENOTYPING; LABORATORY TEST; MALE; SEROLOGY; T LYMPHOCYTE;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 34248571398     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822007000100006     Document Type: Article

References (20)

1. Brito-Melo GE, Martins-Filho OA, Carneiro-Proietti AB, Catalan-Soares B, Ribas JG, Thorum GW, Barbosa-Stancioli EF. Phenotypic study of peripheral blood leucocytes in HTLV-1-infected individuals from Minas Gerais, Brazil. Scandnavian Journal of Immunology 55:621-628, 2002.
2. Brito-Melo GE, Souza JG, Barbosa-Stancioli EF, Carneiro-Proietti AB, Catalan-Soares B, Ribas JG, Thorum GW, Rocha RD, Martins-Filho OA, Grupo Interdisciplinar de Pesquisas em HTLV. Establishing phenotypic features associated with morbidity in human T-cell lymphotropic virus type 1 infection. Clinical Diagnostic and Laboratory Immunology 11:1105-1110, 2004.
3. Carneiro-Proietti ABF, Ribas JGR, Catalan-Soares BC, Martins ML, Brito-Melo GEA, Martins-Filho OA, Pinheiro SR, Araújo AQC, Galvão-Castro B, Oliveira MST, Guedes AC, Proietti FA. Infecção e doença pelos vírus linfotrópicos humanos de células T (HTLV-1/2) no Brasil. Revista da Sociedade Brasileira de Medicina Tropical 35: 499-508, 2002.
4. Catalan-Soares B, Carneiro-Proietti AB, Proietti FA, Interdisciplinary HTLV Research Group. Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): serological screening prevalence rates in blood donors from large urban areas in Brazil. Cadernos de Saúde Pública 21:926-931, 2005.
5. Hannet I, Erkeller-Yuksel F, Lydyard P, Deneys V, DeBruyere M. Developmental and maturational changes in human blood lymphocyte subpopulations. Immunology Today 13:215-218, 1992.
6. Jacobson S, Krichavsky M, Flerlage N, Levin M. Immunopathogenesis of HTLV-1 associated neurologic disease: massive latent HTLV-1 infection in bone marrow of HAM/TSP patients. Leukemia 3 (suppl): 73-75, 1997.
7. Jacobson S, Shida H, Mcfarlin E, Fauci AS, Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-1 pX in patients with HTLV-1 associated neurological disease. Nature 348: 245-248, 1990.
8. Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. The Journal of the American Medical Association 271:703-707, 1994.
9. Kajiyama W, Kashiwagi S, Ikematsu H, Hayashi J, Noruma H, Okochi K. Intrafamilial transmission of adult T-cell leukemia virus. Journal of Infectious Diseases 154:851-857, 1986.
10. Kitajima I, Yamamoto K, Sato K, Nakajima Y, Nakajima T, Maruyama I, Osame M, Nishioka K. Detection of human T cell lymphotropic virus type I proviral DNA and its gene expression in synovial cells in chronic inflammatory arthropathy. Journal of Clinical Investigation 88:1315-1322, 1991.
11. Kubota R, Soldan SS, Martin R, Jacobson S. Selected cytotoxic T lymphocytes with high specificity for HTLV-1 in cerebrospinal fluid from a HAM/TSP patient. Journal of Neurovirology 8:53-57, 2002.
12. Macatonia SE, Cruickshank JK, Rudge P, Knight SC. Dendritic cells from patients with tropical spastic paraparesis are infected with HTLV-1 and stimulate autologous lymphocyte proliferation. AIDS Research and Human Retroviruses 8:1699-1706, 1992.
13. Murphy EL, Figueroa P, Gibbs WN, Brathwaite A, Holding-Cobham M, Waters D, Cranston B, Hanchard B, Blattner WA. Sexual transmission of human Tlymphotropic virus type-I. Annals of Internal Medicine 111:555-560, 1989.
14. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M. HTLV-1 associated myelopathy, a new clinical entity. Lancet 1: 1031-1032, 1986.
15. Poiesz BJ, Ruscetti FW, Reitz MS, Kalyanaraman VS, Gallo RC. Isolation of a new type C retrovirus (HTLV) in primary uncultures cells of a patient with Serary T cell leukemia. Nature 294:268-271, 1981.
16. Popovic M, Reitz MS, Sarngadharan MG. The virus of Japanese adult T-cell leukaemia is a member of the T-cell leukaemia virus group. Nature 300:63-66, 1982.
17. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. Global epidemiology of HTLV-1 infection and associated diseases. Oncogene 24:6058-6068, 2005.
18. Swets JA. Measuring the accuracy of diagnostic systems. Science 240:1285-1293, 1988.
19. Taylor GP. Pathogenesis and treatment of HTLV-1 associated myelopathy. Sexually Transmitted Infections 74:316-322, 1998.
20. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clinical Chemistry 39:561-577, 1993.